Dr. Cristofanilli on Endocrine Therapy for Breast Cancer

Massimo Cristofanilli, MD
Published Online: Sunday, Sep 17, 2017



Massimo Cristofanilli, MD, professor of medicine, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, discusses endocrine therapy for patients with breast cancer.

According to Cristofanilli, endocrine therapy is the most important therapy that is used in adjuvant prevention and management of metastatic breast cancer. The vast majority of patients with breast cancer have an estrogen receptor (ER)-positive disease, which responds well to endocrine therapy.

Understanding the molecular pathway has helped the development of new drugs for patients, states Cristofanilli.
 


Massimo Cristofanilli, MD, professor of medicine, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, discusses endocrine therapy for patients with breast cancer.

According to Cristofanilli, endocrine therapy is the most important therapy that is used in adjuvant prevention and management of metastatic breast cancer. The vast majority of patients with breast cancer have an estrogen receptor (ER)-positive disease, which responds well to endocrine therapy.

Understanding the molecular pathway has helped the development of new drugs for patients, states Cristofanilli.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Leveraging New Evidence in the Context of Evolving Early-Stage Treatment Standards in HER2-Positive Breast CancerJan 30, 20181.5
14th Annual School of Breast Oncology® OnlineFeb 10, 201825
Publication Bottom Border
Border Publication
x